Summary.-Electrophoresis of cytosol prepared from normal and malignant tissue samples of uterine cervix and endometrium revealed interesting differences which may be relevant to the characteristic alterations in glucose metabolism associated with tumour development. Hexokinase II was detected in 30% of the cancer material from both sources, but in none of the samples of normal cervix. A duplet band of 6-phosphogluconate dehydrogenase was seen in the majority of the cancer samples but in no sample of normal cervix; it appeared to be partly due to ageing of the sample, and is not phenotypically related to the malignant process. Analysis of genetic variance for phosphoglucomutase at the PGM1 locus revealed a highly significant excess of the PGM1-1 phenotype in patients with cancer of the endometrium, which may reflect susceptibility to endometrial cancer in patients with this phenotype. At the PGM2 locus, samples of malignant cervix were deficient in "Band f" compared with normal cervix samples, all of which showed this band. Conversely, gene products of the PGM3 locus were found in most samples of malignant cervix and a small minority of normal cervix samples. Compared with the isomorphic distribution of lactate dehydrogenase enzymes in normal uterine tissue, cancers showed a shift towards either a more anodal or a more cathodal pattern. The former may be associated with tumours enjoying a good oxygen supply, and the latter with tumours which, because of their depth or poor blood supply have to function under less aerobic conditions. WE HAVE PREVIOUSLY REPORTED a significant increase in activity of enzymes concerned with glucose metabolism in cancers of the human cervix uteri compared with normal cervical epithelium (Marshall et al., 1978a). This increase was noted for enzymes of the direct oxidative pathway and for those of the glycolytic pathway. Kinetic studies demonstrated differences in behaviour of aldolase and pyruvate kinase of normal and malignant cervical epithelium, with respect to substrate affinity and response to certain activators and inhibitors, and suggested that cervical cancers may differ from normal cervical epithelium not merely in having higher total enzyme activity but also in having different molecular forms ofthese enzymes (Marshall et al., 1978b). We were unable to obtain satisfactory results with zone electrophoresis to answer this question for these two enzymes, but were stimulated to apply these techniques to other enzymes in the hope that such efforts might throw some light on the regulation of these metabolic pathways in human tumours, and might reveal phenotypic differences between normal and malignant cells. This paper reports our findings with 4 enzymes with which differences in the Correspondence and reprints:
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MATERIALS AND) METHODS
General. Samples of normal and malignant tissue from the cervix and body of the uterus Awere collected, homogenized and centrifuged to prepare 105,000g supernatant fractions for assay of enzyme activities, as described in our earlier report (Marshall et al., 1978a) , which also lists the source of the reagents Ahich were used in the present work. Protein concentration wNas determined by the method of LowN-ry and haemoglobin according to Drabkin & Austin (1932) . The pH of all solutions wNras adjusted at 20°C. Starch gels wN-ere prepared at a concentration of 12-5% (w/v) (b) 6-Phosphogluconate dehydrogenase (EC 1.1.1.44; 6-phospho-D-gluconate-NADP+ oxidoreductase. decarboxylating). These were based on the method described above for hexokinase (Brewer & Sing, 1970) . The gel and tank buffers were as for the previous enzyme, except that NADP was added to the cathode compartment to give a final concentration of 0 02mM to improve resolution and yield bands of higher intensity. The stain comprised 100mM Tris/HCl, pH 7-8; 10mM MgC92; 0 2mM NADP; 0 6mM 6-phosphogluconate; 0-33mM PMS; and 0-24mM NBT.
(c) Phosphoglucomutase (EC 2.7.5.1; D-glucose-1, 6-biphosphate: -D-glucose-1-phosphate phosphotransferase). These were based on the method of Spencer et al. (1964) . The reservoir buffer was 01M Tris; 0dIM maleic acid; 001M EDTA, disodium salt; and OO1M MgCI2; and the pH *xAas adjusted to 7*6 with 5M NaOH. The gel buffer wras a 10-fold dilution of the reservoir buffer. The stain comprised 100mM Tris/HCl, pH 7-3; 5inM MgCl2; 0-2mM NADP; 5mM glucose 1-phosphate (containing 1% glucose 1,6-diphosphate); 0-24mM NBT; 0-33mM PMS; and G6PD, 0 33 u/ml.
(d) Lactate dehydrogenase (EC 1.1.1.27; L-lactate: NAD+ oxidoreductase). These were based on the method of Dietz & Lubrano (1967) . The reservoir buffer consisted of 5mM tris and 38mM glycine adjusted to pH 8*3. The stain was 50mM Tris/HCl, pH 8-0; 500mM sodium lactate; 2mM NAD; 0-24mM NBT; and 0-33mM PMS.
RESULTS

Hexokinase
Katzen & Schimke (1965) separated 4 zones of hexokinase activity from rat tissues, designated HKI-HKIV in order of increasing anodal mobility. HKI, II and III could be detected when the staining solution contained 5 x 10-4M 3M. J. AIARSHALL, F. E. NEAL ANI) D. M. GOLDBERG glucose, whereas HKIV, found in liver, required 0 Im glucose concentration in the stain. HKIII, in contrast to HKI annd II, was inhibited bv glucose concentrations in the staining solution greater than about 10-2AI, a restilt confirmed for human hexokinase isoenzymes by Rogers et al.
( 1 975). In the present work no additional bands of activity were demonstrated in 1 I normal and malignant specimens stained with solutions containiing 0-IAi glucose as opposed to 2mM glucose and, therefore, becauise of the (langer of inhibiting HKIII if present, a concentration of 2mM glucose in the staining solution was routinely used for development of hexokinase isoenzymes.
OnlY samples with activity greater than 1 00 mu/ml proved sufficientlv active for our detection system, of wlhich 19 wvere from normal cervix epithelium, 19 were from malignant cervix and 8 were from malignant endometrium.
All showed a low mobility zone witlh a duplet structure presumably corresponding to the duplet zone of HKI described by Rogers et al. (1975 To accelerate the process of duplet formation, normal and malignant samples were incubated at 370C, alone, and in the presence of 0 2mM NADP or 0 5mAi mercaptoethanol before electrophoresis. After 24 h at 37°C, 3/5 malignant samples showed the appearance of a duplet, whereas 6 normal samples were unaltered. NADP and mercaptoethanol had no further effect. No correlation between haemoglobin content and the presence of double bands was found. It is unlikely that erythrocytes are the source of the second band.
Phosphoglucorn utase
This enzyme is thought to be coded in 3 separate loci, designated PGMA1, PGM2 and P(GM/J3 (Harris et al., 1968) . PGM1 contains 3 common genetic variants noted by Spencer et al.
(1 964) which are transmitted by autosomal inheritance althouigh, according to a more recent report (Bark et al., 1976) , further common phenotypes may (Sato et al., 1969) , in human hepatomas (Balinsky et al., 1973; Hammond & Balinsky, 1978) and in all of 53 primary human tumours investigated (Kamel & Schwarzfischer, 1975 (Bernstein, 1977) . Our failure to detect HKII in the majority of tumours precludes this change being an obligatory event in neoplasia. This conclusion is supported by a recent paper describing the presence of HKII in only 13/27 human glial tumours (Bennett et al., 1978) .
6-Phosphoglatconate dehydroyenase Latner (1967) reported a single band of PGDH in cervical carcinomas after starchgel electrophoresis. The mobility was variable from tumouir to tumour, but inequalities of mobility were abolished by adding excess NADP. He offered 3 explanations for this variability of the isoenzyme: (a) gene mutation; (b) ageing of cells in the population; and (c) variable NADP content of the tumours. Differences in electrophoretic mobility of 6-phosphogluconate dehydrogenase from malignant melanoma and normal skin have been described (Prasad et al., 1974) Tumour. tissue occasionally showed a slowermoving band which was also present in muscle. TIhe two bands differed in their binding capacity for NADP. During storage, many malignant samples developed a slower band of 6-phosphogluconate dehydrogenase after electrophoresis. sible reactions resulting in loss of mobility are: loss of a cofactor, deamidation, desialysation, oxidation of sulphydryl groups, and conformational changes (Epstein and Schechter, 1968) . Preincubation of normal and malignant samples with NADP or mercaptoethanol, however, evoked no change in mobility, whereas incubation at 37°C for 24 h resulted in duplet bands in 3/5 malignant samples. This reflects a difference in the microenvironment between the normal and the malignant state; perhaps the redox potential or the level of protein catabolism is the relevant factor.
Phosphoglucomutase
Assuming that the phenotypes observed for this enzyme in the uterus are characteristic of the individual genotype, the association between the PGM1I phenotype and women with endometrial carcinoma may reflect association between the disease and some genetically determined aetiological factor. Women with PGM12 may be less susceptible. A comparable situation has been demonstrated by Cassimos et al. (1973) , who showed an association between glucose-6-phosphate dehydrogenase deficiency and a low incidence of cancer.
In the tissues studied, 2 instead of the 3 bands of PGM2 seen in erythrocyte haemolysates were detected. This may represent genuine tissue variation or a feature of the electrophoretic technique. The second (Band f) was not detected in 13/18 malignant cervix samples, whereas all 18 normal cervix samples showed it. The most intense band (e), which was always present, may be the primary gene product and Band f may arise by subsequent modification; absence of Band f might suggest inactivity of the modifying agent in most cervical cancers.
Two or three fast bands representing the ,PGM3 locus were detected in 1.5/18 malignant cervix samples and 2/18 normal samples. This difference in detection of PGM3 bands presumably reflects an activity increase of enzymes of this locus due to malignant change. It is not due to higher total phosphoglucomutase activity of cancer samples per se since, as with other enzymes, the amount loaded on to the gel was quite constant. The significance of such an inicrease is uncertain. Although differences in specificity, affinity and molecular weight are known between the various PGM gene products (Harris et al., 1968) , the function of PGM3 is enigmatic. PGM1 is thought to be mainly involved with glucose-] -phosphate (GIP) as substrate, whereas PGM2 uises ribose-l-phosphate (RIP) more efficiently. PQM3 has a very high LD4 shift compared with an LD1-+LD5 shift. This finding of increased LD5 content is in line with extensive studies of other human tumours (Goldman et al., 1964; Nissen & Bohn, 1965) and is postulated to permit increased rates of glycolysis, since LD5 is less susceptible to inhibition by pyruvate (Latner & Skillen, 1967) .
The surprising observation of an LD1 shift in about a quarter of the samples of carcinoma of the cervix has not been previously reported, although this plhenomenon has been observed in other tumours (Henderson et al., 1974; Prasad et al., 1974) . The proportion of H-subunits in human hepatomas seemed to be slightly greater than in normal or host liver (Hammond & Balinsky, 1978 Lactate dehydrogenase (LDH) isoenzyme patterns may change in tumours according to physiological stimuli rather than as a consequence of reprogramming of protein synthesis necessary for neoplastic growth. Oxygen tension, hormonal changes and virus interaction are reported to cause differential production of LDH subunits (Clark & Yochim, 1969; Prasad et al., 1972) . Perhaps the LDH isoenzyme pattern reflects the oxygen tension in a tumouir. Superficial tumours directly accessible to oxygen may show an LD1 shift, whereas deep tumours with poor vascularization may show an LD5 shift. No such correlation was attempted in this work, but would be worth trying in future.
Significant, differences in LDH isoenzyme patterns were not observed in endometrial carcinoma compared with normal endometrium. Fottrell et al. (1974) reported 70-76% M-subunits in 3 cases of carcinoma of human endometrium compared with 11% in normal endometrium samples during the proliferative phase of the menstrual cycle and 32% during the secretory phase. It is difficult to assess the significance of this work because of the small number of tumours examined, and because the variance of results in the control material was not indicated.
CONCLUSION
Differences in the isoenzym e patterns for the 4 enzymes examined have been demonstrated between normal and malignant tissues of the human uterus. In the main, these changes are qualitative rather than absolute, and they did not show a significant degree of correlation in individual tumours or in the tumour population as a whole. No cancer-specific isoenzymic forms were elucidated. The closest to this objective was the failure of expression of the PGM3 locus in normal cervix epithelium and the frequent occurrence of a duplet form of 6-phosphogluconate dehydrogenase in malignant cervix which was never seen in normal tissue. Further work is needed to elucidate the chemical basis for this phenomenon, and the genetic basis for the other differences, which may be due to changes in the cell population making up the biopsy sample. The relatively small number of samples did not encourage a detailed analysis of the relationship between the observed phenomena in cancers and the type of tumour, its sensitivity to therapy, its degree of invasiveness, and whether these phenomena have any prognostic significance. These goals are worthy of future study. 
